Literature DB >> 8402555

Chromosomes in the genesis and progression of ependymomas.

S R Rogatto1, C Casartelli, C A Rainho, J Barbieri-Neto.   

Abstract

Cytogenetic analysis was performed on cultures of primary ependymal tumors with different degrees of malignancy (I-IV) obtained from four patients, none of whom had received therapy before karyotypic evaluation. The most common abnormalities were monosomy 17 and 22 in four cases and losses of sex chromosomes in three cases. Structural rearrangements of chromosome 2 were a finding for all cases and involved loss of material at 2q32-34. Other structural chromosome abnormalities detected involved chromosomes 4, 6, 10, 11, 12, and X. We also reviewed data on 22 cases previously reported.

Entities:  

Mesh:

Year:  1993        PMID: 8402555     DOI: 10.1016/0165-4608(93)90093-2

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  10 in total

Review 1.  Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies.

Authors:  Mandeep S Tamber; Krishan Bansal; Muh-Lii Liang; Todd G Mainprize; Bodour Salhia; Paul Northcott; Michael Taylor; James T Rutka
Journal:  Childs Nerv Syst       Date:  2006-09-02       Impact factor: 1.475

2.  Recurrent anaplastic ependymoma with an abnormal karyotype and c-myc proto-oncogene overexpression.

Authors:  M Debiec-Rychter; J Lasota; J Alwasiak; P P Liberski
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

3.  Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.

Authors:  Y Hirose; K Aldape; A Bollen; C D James; D Brat; K Lamborn; M Berger; B G Feuerstein
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

4.  Nab1, a corepressor of NGFI-A (Egr-1), contains an active transcriptional repression domain.

Authors:  A H Swirnoff; E D Apel; J Svaren; B R Sevetson; D B Zimonjic; N C Popescu; J Milbrandt
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

5.  Proliferation- and apoptosis-related proteins in intracranial ependymomas: an immunohistochemical analysis.

Authors:  M J T Verstegen; D Troost S Leenstra; H Ijlst-Keizers; D A Bosch
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

6.  Molecular cytogenetic studies of pediatric ependymomas.

Authors:  D L Kramer; A H Parmiter; L B Rorke; L N Sutton; J A Biegel
Journal:  J Neurooncol       Date:  1998-03       Impact factor: 4.130

Review 7.  Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

Authors:  Judith M de Bont; Roger J Packer; Erna M Michiels; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

Review 8.  The genetic and epigenetic basis of ependymoma.

Authors:  Stephen C Mack; Michael D Taylor
Journal:  Childs Nerv Syst       Date:  2009-06-18       Impact factor: 1.475

Review 9.  Ependymoma.

Authors:  Charles Teo; Peter Nakaji; Patricia Symons; Vivienne Tobias; Richard Cohn; Robert Smee
Journal:  Childs Nerv Syst       Date:  2003-05-22       Impact factor: 1.475

10.  Profile of Chromosomal Alterations, Chromosomal Instability and Clonal Heterogeneity in Colombian Farmers Exposed to Pesticides.

Authors:  María Paula Meléndez-Flórez; Duvan Sebastián Valbuena; Sebastián Cepeda; Nelson Rangel; Maribel Forero-Castro; María Martínez-Agüero; Milena Rondón-Lagos
Journal:  Front Genet       Date:  2022-02-24       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.